One hundred and two consecutive patients with cerebral haematoma were prospectively allocated to one of two groups according to their CT on admission. Group 1 patients were thought to have a high probability of an underlying structural lesion and underwent cerebral angiography acutely. If normal, this was repeated at three months. Group 2 patients were thought not to have such a lesion and underwent angiography at three months. Patients older than the mean age of the study population, and hypertensive patients were much less likely to harbour an aneurysm or arteriovenous malformation than younger or normotensive patients (p < 0-01; sensitivity 87-9%, specificity 88.6%). An aneurysm or arteriovenous malformation was the cause of haemorrhage in 12-8% of hypertensive patients, in 309% of patients with haematoma involving the basal ganglia, and 18-2% of those with posterior fossa haemorrhage. Features of CT in isolation give a sensitivity of 77-2% and a specificity of 84-2%. Follow up angiography in group 1 showed an arteriovenous malformation in one of seven patients in whom the original study was normal. These results contrast sharply with data from previous retrospective studies. The decision to investigate a patient with cerebral haematoma should be primarily based on the patient's clinical condition, rather than on the site of haemorrhage. (7 Neurol Neurosurg Psychiatry 1994;57: 1180-1186 Stroke is caused by spontaneous cerebral haemorrhage in 4% to 119% of patients"2 although rates of up to 40% have been quoted.3 Acute mortality ranges from 18°% to 75%, depending on the size and position of the haematoma and the age and clinical condition of the patient.'45 To prevent recurrence, it is important to identify patients in whom haemorrhage is secondary to an underlying structural lesion, such as an aneurysm, vascular malformation, or tumour. Pathological studies have indicated that primary haemorrhage is most likely to occur in certain sites-in particular the basal ganglia and posterior fossa.6 Factors such as -age, pre-existing systemic hypertension, and haematoma location are commonly employed in selecting patients for angiography. The influence of clinical features and CT on final diagnosis has been described retrospectively,7-" but to our knowledge there has been no prospective angiographic assessment in life of the relative frequency of primary and secondary haemorrhage in patients with cerebral haematoma.
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Methods
All patients presenting consecutively to this hospital between 1989 and 1992 with spontaneous cerebral haematoma were entered into the study. They were assigned to one of two groups after evaluation of their CT on admission by two or three consultant neuroradiologists. If the haematoma was thought likely to be due to an underlying structural cause, angiography was carried out as soon as the patient's condition allowed, and was repeated three months later if negative (group 1). If, however, such a lesion was not suspected, angiography was delayed by three months (group 2).
The radiologists were unaware of clinical details other than the patients' ages before assessing the admission CT. Clinical information was recorded for each patient after the CT assessment was made. showed causative arteriovenous malformations in 23 and aneurysms in nine. In one patient, CT showed an underlying tumour. Angiography was not performed and an oligodendroglioma was confirmed by biopsy. In another patient, with known melanoma, the haematoma was in association with several other lesions typical of metastases, and CT follow up confirmed a metastasis at the site of the haematoma. No abnormality was found in six patients, four of whom were aged under 35 and had frontal, frontotemporal, or temporoparietal haematomas. One 52 year old patient had a temporoparietal haematoma in association with subarachnoid blood, and one 48 year old hypertensive patient had a basal ganglia haemorrhage. Four patients in group 1 had an initial angiogram that showed only mass effect, and these patients failed to attend for further angiography.
Forty two of 58 patients assigned to group 2 completed the protocol. Angiography showed an arteriovenous malformation in eight and an aneurysm in two. No abnormality was found at delayed angiography in 32. Table 3 presents the data for the 10 patients from group 2 in whom an angiographic structural lesion was found. Table 4 details the findings in patients with normal and raised blood pressure. Forty seven per cent of all patients were hypertensive. There was a highly significant difference between the two (p < 0-001) relative to finding a structural lesion by chance.
The influence of age was assessed by separating the patients into two cohorts: those above and those below the mean age of the study population. There was a highly significant difference between the two age groups (p < 0-01). Table 5 details the angiographic findings.
There was an even greater discrepancy (p < 0 01) when the results were compared between those who were hypertensive and older than the mean age of the study, and those who were normotensive and below the mean age ( 
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Seven patients in group 1 had angiography repeated at three months. These studies identified one arteriovenous malformation, and in three patients showed prominent small veins that were attributed to haemorrhage or surgery performed to evacuate the haematoma.
Computed tomography showed only intraventricular haemorrhage in three patients, each of whom was normotensive and aged under 40. Two had a choroidal arteriovenous malformation, and in one no angiographic abnormality was found. Further angiography was refused by this child's parents, but subsequent MRI showed no evidence of vascular abnormality.
Three incidental aneurysms were detected during angiography in two patients, remote from the site of haemorrhage. These patients have been included in the "non-structural" group.
There primary haemorrhage was most likely to occur in certain sites-notably the striatum and posterior fossa. It would seem that many physicians have extrapolated this to the false assumption that haemorrhage in the basal ganglia or posterior fossa is almost exclusively due to hypertension. Douglas and Haerer," for example, state that when the diagnosis of hypertensive haemorrhage is obvious, angiography is "ethically unacceptable", whereas others have suggested that angiography should be restricted to patients with haemor-6 < . r ; :~n jrhage outside the basal ganglia.'617 This led McCormick and Rosenfield in 1973 to state that "the assumption that hypertension causes most massive brain haemorrhage has become virtual dogma", and "the majority of reports (on this subject) are so poorly controlled and documented as to be of little scientific validity". In their necropsy review of 144 patients who died from massive brain haemorrhage, 36% of patients with hypertension had another cause of haemorrhage, a third having causative arteriovenous malformation or aneurysms; and 19 normotensive and five hypertensive patients had striatal haemorrhage due to a non-hypertensive aetiology.4 Our data confirm the findings of McCormick and Rosenfield: at least 12-8% of our hypertensive patients had an arteriovenous malformation or aneurysm, and at least 31 % of patients with basal ganglia haemorrhage and 18% of those with posterior fossa haemorrhage had such a lesion. It is especially important not to ascribe haemorrhage in these sites to non-structural causes as there is evidence that such arteriovenous malformations are more likely to bleed than those in other locations. '8 These assumptions have led to exclusions and omissions from many studies dealing with cerebral haematoma."7-1 19-21 Weisberg and colleagues have written extensively on the clinical features in those with haematomas in varying sites,'9-21 but few of the patients had angiography. Loes et al9 reviewed the records and radiology of 67 patients referred for angiography after cerebral haemorrhage. In addition to this initial selection, patients with posterior fossa, basal ganglia, or thalamic haemorrhage were excluded, as were patients with bleeding diathesis. Such selection may exclude patients liable to rebleed from structural lesions. In our study three patients had haemorrhage during warfarin treatment, all with an international normalised ratio of greater than 3 The sensitivity and specificity of CT in predicting an angiographic abnormality seem disappointing in this study when compared with others,7-'0 who have found that CT is accurate in predicting the presence of an underlying structural lesion. These authors have used entry criteria less broad than ours. We included patients with basal ganglia or posterior fossa haemorrhage, tending to place them in group 2 according to available literature, and were proved wrong on several occasions. Hayward and O'Reilly,8 using a first generation CT scanner with a 160 x 160 matrix, reported that CT is 90% accurate in predicting the cause of cerebral haemorrhage, but excluded all patients with posterior fossa haemorrhage, those below the age of 21, and patients on whom angiography was not performed. More recently, in a retrospective study of 149 patients with cerebral haematoma, Laissy et al reported sensitivity and specificity of CT to be 96% and 100% respectively in detecting arteriovenous malformation or aneurysm, using a combination of CT findings, including site of haemorrhage and the presence or absence of intraventricular or subarachnoid haemorrhage.7 Their 149 patients were selected from a total of 452, however, and no information is given as to how patients were selected for angiography. Similar to McCormick et al, they found that neither age nor systemic blood pressure were good predictors of patients with abnormal angiograms. There were fewer aneurysms in our study population compared with other studies.7910
We attributed this to the fact that we excluded patients whose scans predominantly showed subarachnoid haemorrhage.
Repeating angiography when an acute study does not show a structural lesion has been advocated by Willinsky et al,22 who state that up to 15% of small arteriovenous malformations were not shown on the first examination, presumably due to a mass effect from haematoma. We discovered one arteriovenous malformation at follow up angiography, which had not been previously apparent, and Laissy et al found three "angiomas" in this manner.7 An alternative approach, used in our group 2, is not to perform angiography acutely in those patients for whom surgery is not contemplated, but to wait until any mass effect had subsided. We discovered an arteriovenous malformation or aneurysm in 10 such patients, none of whom came to harm by the delay in diagnosis. By the same token, 48 patients were saved from having two rather than one angiogram. We would accept, however, that delay in diagnosing and treating an aneurysm may have serious consequences.
Like us, Loes et al 9 found an association between location of haematoma and angiographic abnormality, and speculate that the small proportion of structural lesions found with haematoma in the parietal and occipital lobes may be related to the predilection of amyloid angiopathy for these areas.23 This diagnosis may be difficult to make, and its occurrence might contribute to the small numbers of positive angiograms in elderly patients.
Of course, there may be many diagnoses hidden within a diagnosis of "primary" haemorrhage: lesions such as cavernous haemangioma and vasculitis, for example, are unlikely to be shown by angiography.'425 Other conditions predisposing to cerebral haemorrhage such as bleeding diatheses, diabetes mellitus, and liver disease4 2$28 should be detectable by clinical and laboratory investigation. A history of drug abuse may be difficult to elicit, but can cause cerebral haemorrhage,29 30 and haemorrhage into a tumour will sometimes not reveal the underlying cause until the haematoma has absorbed.3' 32 In our experience this is unusual, however.
Although this study collected consecutive patients prospectively, they were a selected group by referral to our hospital. Therefore patients who were considered too sick to be transferred and those dying before arrival were excluded. Other logistic factors may have biased the series, which might explain the paucity of patients with tumours, as such patients may not have been sent to us. Similarly, elderly patients, in whom the presumed diagnosis was of a non-structural lesion, may not have been referred.
Such selection, although unintentional on our part, may have biased our results by increasing the percentage of patients in whom a structural lesion was found. We have no measure of how many patients with cerebral haemorrhage are not referred because the clinician believes they have a "primary" bleed, nor how such a clinician makes this decision. Similarly, we do not know how often the diagnosis of haemorrhage is not made because the patient presenting with a stroke does not have CT. As the mean age of our study group was 46-4 (range 7-71) years, we suspect that many elderly patients who are likely to have amyloid angiopathy were not referred.
We used angiography as our gold standard and it is questionable whether MRI or magnetic resonance angiography (MRA) would be preferable. Whereas MRI may throw further light on the cause of haemorrhage within the "primary" group, there is as yet no evidence to suggest that it would be as sensitive as angiography in the detection of arteriovenous malformation. 33 Willinsky et al state that very small arteriovenous malformations are, by their nature, occult on MRI." In one of our patients, MRI did not detect a small arteriovenous malformation, but MRA was not performed. A prospective comparison between MRI, MRA, and angiography in patients with cerebral haematoma is currently under assessment at this hospital.
In summary, we believe our data support the recommendation that angiography should be considered in all patients with cerebral haematoma, regardless of the site of haemorrhage, or a history of hypertension, and that the clinical condition of the patient should be the deciding factor. We further believe that an angiogram that shows no abnormality apart from mass effect should be repeated after an appropriate interval, especially if the patient is young and normotensive. 
